A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study Meeting Abstract
| Authors: | Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Geneus, S.; Godfrey, L.; Norton, L.; Hudis, C. |
| Abstract Title: | A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study |
| Meeting Title: | 31st Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 69 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2008 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2009-01-01 |
| Start Page: | 384S |
| Language: | English |
| ACCESSION: | ISI:000262583201584 |
| PROVIDER: | wos |
| DOI: | 10.1158/0008-5472.SABCS-6121 |
| Notes: | --- - Meeting Abstract : 6121 - Suppl. S - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
